乳腺癌随访和药物副作用管理策略的研究进展

乳腺癌是全球女性发病率最高的恶性肿瘤,随着诊断技术及治疗手段的不断提高,乳腺癌患者接受系统治疗后生存期明显延长。乳腺癌患者需要长时间的随访以便及早监测到局部复发和远处转移。此外,激素敏感性乳腺癌患者还需要给予5~10年的内分泌治疗,针对其副作用的全程管理也需要随访,进而提高患者的生活质量,减轻患者疾病负担。本文就近年来乳腺癌随访相关方面进行简要综述。

Research progress on follow - up and drug side effect management strategy of breast cancer

Breast cancer is the malignant tumor with the highest incidence in women.With the continuous improvement of diagnostic technology and treatment methods,the survival period of breast cancer patients after receiving systemic therapy has been significantly prolonged.This requires long-term follow-up for early detection of local recurrence and distant metastasis.In addition,hormone-sensitive breast cancer also needs to be given endocrine therapy for 5~10 years,and the full management of side effects also requires follow-up,improve the quality of life of patients,and provide patients with physical and psychological support.This article makes a brief review on breast cancer follow-up related aspects in recent years.